Cefadroxilhow supplied

Jump to navigation Jump to search
Cefadroxil
DURICEF® FDA Package Insert
Description
Clinical Pharmacology
Microbiology
Indications and Usage
Contraindications
Warnings and Precautions
Adverse Reactions
Overdosage
Dosage and Administration
How Supplied

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

How Supplied

Cefadroxil For Oral Suspension, USP is available in:

The 125 mg per 5 mL of reconstituted suspension* contains cefadroxil monohydrate equivalent to 125 mg with a light orange colored powder forming orange suspension on constitution with water. The resulting suspension has a characteristic mixed fruit flavor and is available as follows:

NDC 63304-972-04 100 mL bottles

The 250 mg per 5 mL of reconstituted suspension* contains cefadroxil monohydrate equivalent to 250 mg with a light orange colored powder forming orange suspension on constitution with water. The resulting suspension has a characteristic mixed fruit flavor and is available as follows:

NDC 63304-973-03 50 mL bottles

NDC 63304-973-04 100 mL bottles

The 500 mg per 5 mL of reconstituted suspension* contains cefadroxil monohydrate equivalent to 500 mg with a light orange colored powder forming orange suspension on constitution with water. The resulting suspension has a characteristic mixed fruit flavor and is available as follows:

NDC 63304-974-01 75 mL bottles

NDC 63304-974-04 100 mL bottles

  • SHAKE ORAL SUSPENSION WELL BEFORE USING. Keep bottle tightly closed. After reconstitution, store in refrigerator. Any unused portion of the reconstituted suspension must be discarded after 14 days.

Prior to reconstitution: Store at 20 - 25° C (68 - 77° F). (See USP Controlled Room Temperature).[1]

References

  1. "http://www.accessdata.fda.gov/drugsatfda_docs/label/2007/050512s046,050527s022,050528s020lbl.pdf" (PDF). External link in |title= (help)

Adapted from the FDA Package Insert.